Ruderman Eric M
Northwestern University Feinberg School of Medicine, 675 North St. Clair, Suite 14-100, Chicago, IL 60611, USA.
Curr Rheumatol Rep. 2005 Aug;7(4):313-8. doi: 10.1007/s11926-005-0042-7.
Treatment of psoriatic arthritis, like the treatment of rheumatoid arthritis, now commonly includes the use of inhibitors of tumor necrosis factor in addition to traditional synthetic disease-modifying antirheumatic drugs. This paper examines the most recent data from therapeutic trials in psoriatic arthritis, with particular emphasis on the effectiveness of the tumor necrosis factor inhibitors. Recent data on potential future therapies is discussed as well, along with data on the mechanisms of current therapies that may have relevance for future treatment approaches.
银屑病关节炎的治疗与类风湿关节炎的治疗一样，目前除了传统的合成抗风湿药物外，通常还包括使用肿瘤坏死因子抑制剂。本文审视了银屑病关节炎治疗试验的最新数据，特别强调了肿瘤坏死因子抑制剂的有效性。还讨论了潜在未来疗法的最新数据，以及当前疗法的作用机制数据，这些数据可能与未来的治疗方法相关。
